Samjin Pharmaceutical CEO Choi Ji-hyun Reports Minor Change in Stake via Open Market Trades

Samjin Pharmaceutical CEO Choi Ji-hyun net sold 651 shares through open market trades between June 25 and July 2, 2026, reducing holdings from 338,692 to 338,041 shares.
The total outstanding shares decreased to 13,320,000 due to a treasury stock cancellation in November 2025, which caused Choi's ownership percentage to rise slightly from 2.44% to 2.54% despite the net sale.
These routine personal trades have negligible impact on stock price or corporate control and do not signal any new capital allocation or dividend policy shifts.
[AI Summary]This is a standard insider ownership change report with no new capital market activity or shareholder return implications, resulting in a neutral investment impact.